Which cardiovascular/metabolic comorbidity is commonly associated with obesity and should be evaluated?

Prepare for the Registered Respiratory Therapist CSE with comprehensive flashcards and multiple-choice questions, including hints and explanations. Ace your exam with confidence!

Multiple Choice

Which cardiovascular/metabolic comorbidity is commonly associated with obesity and should be evaluated?

Obesity commonly drives cardiovascular and pulmonary blood-pressure problems, so screening for hypertension is a key step in evaluating a patient with obesity. The extra body mass increases blood volume and cardiac output, while metabolic changes (like insulin resistance) can activate mechanisms that raise systemic vascular tone and pressure. Over time, this leads to systemic hypertension, a frequent and important comorbidity to identify and manage. Obesity can also contribute to pulmonary hypertension, especially when it coexists with hypoventilation or sleep-disordered breathing such as obstructive sleep apnea. Recurrent nocturnal hypoxemia and CO2 retention cause constriction and remodeling of the pulmonary vessels, raising pressures in the pulmonary circulation. That combination makes assessing for both systemic and pulmonary hypertension important in obese patients. While obesity is linked to higher risks of infection and thromboembolic events, those are not the primary chronic cardiometabolic comorbidities clinicians routinely evaluate alongside obesity in this context, making systemic and pulmonary hypertension the most relevant focus.

Obesity commonly drives cardiovascular and pulmonary blood-pressure problems, so screening for hypertension is a key step in evaluating a patient with obesity. The extra body mass increases blood volume and cardiac output, while metabolic changes (like insulin resistance) can activate mechanisms that raise systemic vascular tone and pressure. Over time, this leads to systemic hypertension, a frequent and important comorbidity to identify and manage.

Obesity can also contribute to pulmonary hypertension, especially when it coexists with hypoventilation or sleep-disordered breathing such as obstructive sleep apnea. Recurrent nocturnal hypoxemia and CO2 retention cause constriction and remodeling of the pulmonary vessels, raising pressures in the pulmonary circulation. That combination makes assessing for both systemic and pulmonary hypertension important in obese patients.

While obesity is linked to higher risks of infection and thromboembolic events, those are not the primary chronic cardiometabolic comorbidities clinicians routinely evaluate alongside obesity in this context, making systemic and pulmonary hypertension the most relevant focus.

More practice questions